Toward a more complete understanding of who will benefit from prehospital transfusion
Corresponding Author
Mark H. Yazer
Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
Correspondence
Mark H. Yazer, Vitalant, 3636 Blvd of the Allies, Pittsburgh, PA 15213, USA.
Email: [email protected]
Search for more papers by this authorAndrew P. Cap
U.S. Army Institute of Surgical Research, Department of Medicine, Uniformed Services University, Bethesda, Maryland, USA
Search for more papers by this authorElon Glassberg
Israeli Defense Forces, Medical Corps, Israel; Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel, The Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA
Search for more papers by this authorLaura Green
Barts Health NHS Trust, London, UK
Blizard Institute, Queen Mary, University of London, London, UK
NHS Blood and Transplant, London, UK
Search for more papers by this authorJohn B. Holcomb
Center for Injury Science, Department of Surgery, University of Alabama at Birmingham, Birmingham, USA
Search for more papers by this authorMansoor A. Khan
Department of Abdominal Surgery and Medicine, University Hospitals Sussex, Sussex, UK
Search for more papers by this authorErnest E. Moore
Department of Surgery, Ernest E Moore Shock Trauma Center at Denver Health, University of Colorado Denver, Denver, Colorado, USA
Search for more papers by this authorMatthew D. Neal
Pittsburgh Trauma and Transfusion Medicine Research Center, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
Search for more papers by this authorGavin D. Perkins
Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK; Critical Care Unit, Heartlands Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for more papers by this authorJason L. Sperry
Division of Trauma and General Surgery, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
Search for more papers by this authorDarrell J. Triulzi
Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
Search for more papers by this authorPhilip C. Spinella
Departments of Surgery and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
Search for more papers by this authorCorresponding Author
Mark H. Yazer
Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
Correspondence
Mark H. Yazer, Vitalant, 3636 Blvd of the Allies, Pittsburgh, PA 15213, USA.
Email: [email protected]
Search for more papers by this authorAndrew P. Cap
U.S. Army Institute of Surgical Research, Department of Medicine, Uniformed Services University, Bethesda, Maryland, USA
Search for more papers by this authorElon Glassberg
Israeli Defense Forces, Medical Corps, Israel; Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel, The Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA
Search for more papers by this authorLaura Green
Barts Health NHS Trust, London, UK
Blizard Institute, Queen Mary, University of London, London, UK
NHS Blood and Transplant, London, UK
Search for more papers by this authorJohn B. Holcomb
Center for Injury Science, Department of Surgery, University of Alabama at Birmingham, Birmingham, USA
Search for more papers by this authorMansoor A. Khan
Department of Abdominal Surgery and Medicine, University Hospitals Sussex, Sussex, UK
Search for more papers by this authorErnest E. Moore
Department of Surgery, Ernest E Moore Shock Trauma Center at Denver Health, University of Colorado Denver, Denver, Colorado, USA
Search for more papers by this authorMatthew D. Neal
Pittsburgh Trauma and Transfusion Medicine Research Center, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
Search for more papers by this authorGavin D. Perkins
Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK; Critical Care Unit, Heartlands Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for more papers by this authorJason L. Sperry
Division of Trauma and General Surgery, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
Search for more papers by this authorDarrell J. Triulzi
Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
Search for more papers by this authorPhilip C. Spinella
Departments of Surgery and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
Search for more papers by this author
CONFLICTS OF INTEREST
Matthew D Neal serves on the scientific advisory board of Haima Therapeutics with equity stake. He has received research funding from the NIH, DoD, Haemonetics, and Instrumentation Laboratory. He has received honoraria from Haemonetics and Meredian. Gavin D Perkins declares funding from the NIHR Efficacy and Mechanism Evaluation Programme (14/152/14) and West Midlands Applied Research Collaboration. The other authors have no conflicts of interest to declare. The views expressed are those of the author(s) and not necessarily those of the UK NIHR, the UK Department of Health and Social Care, the US Department of the Army, the US Department of Defense, or the US government.
REFERENCES
- 1Brown JB, Sperry JL, Fombona A, Billiar TR, Peitzman AB, Guyette FX. Pre-trauma center red blood cell transfusion is associated with improved early outcomes in air medical trauma patients. J Am Coll Surg. 2015; 220: 797–808.
- 2Rehn M, Weaver A, Brohi K, Eshelby S, Green L, Røislien J, et al. Effect of prehospital red blood cell transfusion on mortality and time of death in civilian trauma patients. Shock. 2019; 51: 284–8.
- 3Holcomb JB, Swartz MD, DeSantis SM, Greene TJ, Fox EE, Stein DM, et al. Multicenter observational prehospital resuscitation on helicopter study. J Trauma Acute Care Surg. 2017; 83: S83–91.
- 4Nadler R, Tsur AM, Yazer MH, Shinar E, Moshe T, Benov A, et al. Early experience with transfusing low titer group O whole blood in the pre-hospital setting in Israel. Transfusion. 2020; 60(Suppl 3): S10–S6.
- 5Beckett A, Callum J, da Luz LT, Schmid J, Funk C, Glassberg E, et al. Fresh whole blood transfusion capability for special operations forces. Can J Surg. 2015; 58: S153–6.
- 6Levin D, Zur M, Shinar E, Moshe T, Tsur AM, Nadler R, et al. Low-titer group O whole-blood resuscitation in the prehospital setting in Israel: review of the first 2.5 Years' experience. Transfus Med Hemother. 2021; 48: 342–9.
- 7Chen J, Benov A, Nadler R, Darlington DN, Cap AP, Lipsky AM, et al. Prehospital blood transfusion during aeromedical evacuation of trauma patients in Israel: the IDF CSAR experience. Mil Med. 2017; 182: 47–52.
- 8Shackelford SA, Del Junco DJ, Powell-Dunford N, et al. Association of Prehospital Blood Product Transfusion during Medical Evacuation of combat casualties in Afghanistan with acute and 30-day survival. JAMA. 2017; 318: 1581–91.
- 9Sperry JL, Guyette FX, Brown JB, Yazer MH, Triulzi DJ, Early-Young BJ, et al. Prehospital plasma during air medical transport in trauma patients at risk for hemorrhagic shock. N Engl J Med. 2018; 379: 315–26.
- 10Moore HB, Moore EE, Chapman MP, McVaney K, Bryskiewicz G, Blechar R, et al. Plasma-first resuscitation to treat haemorrhagic shock during emergency ground transportation in an urban area: a randomised trial. Lancet. 2018; 392: 283–91.
- 11Osler T, Baker SP, Long W. A modification of the injury severity score that both improves accuracy and simplifies scoring. J Trauma. 1997; 43: 922–5. discussion 5–6.
- 12Gruen DS, Guyette FX, Brown JB, Okonkwo DO, Puccio AM, Campwala IK, et al. Association of Prehospital Plasma with Survival in patients with traumatic brain injury: a secondary analysis of the PAMPer cluster randomized clinical trial. JAMA Netw Open. 2020; 3:e2016869.
- 13Reitz KM, Moore HB, Guyette FX, Sauaia A, Pusateri AE, Moore EE, et al. Prehospital plasma in injured patients is associated with survival principally in blunt injury: results from two randomized prehospital plasma trials. J Trauma Acute Care Surg. 2020; 88: 33–41.
- 14Stettler GR, Moore EE, Moore HB, Nunns GR, Coleman JR, Colvis A, et al. Variability in international normalized ratio and activated partial thromboplastin time after injury are not explained by coagulation factor deficits. J Trauma Acute Care Surg. 2019; 87: 582–9.
- 15Crombie N, Doughty HA, Bishop JRB, Desai A, Dixon EF, Hancox JM, et al. Resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet Haematol. 2022; 9: e250–e61.
- 16Stanworth SJ, Morris TP, Gaarder C, Goslings JC, Maegele M, Cohen MJ, et al. Reappraising the concept of massive transfusion in trauma. Crit Care. 2010; 14: R239.
- 17Tucker H, Avery P, Brohi K, Davenport R, Griggs J, Weaver A, et al. Outcome measures used in clinical research evaluating prehospital blood component transfusion in traumatically injured bleeding patients: a systematic review. J Trauma Acute Care Surg. 2021; 91: 1018–24.
- 18Spinella PC, El Kassar N, Cap AP, et al. Recommended primary outcomes for clinical trials evaluating hemostatic blood products and agents in patients with bleeding: proceedings of a National Heart Lung and blood institute and US Department of defense consensus conference. J Trauma Acute Care Surg. 2021; 91: S19–25.
- 19Holcomb JB, Moore EE, Sperry JL, Jansen JO, Schreiber MA, del Junco DJ, et al. Evidence-based and clinically relevant outcomes for hemorrhage control trauma trials. Ann Surg. 2021; 273: 395–401.
- 20Oyeniyi BT, Fox EE, Scerbo M, Tomasek JS, Wade CE, Holcomb JB. Trends in 1029 trauma deaths at a level 1 trauma center: impact of a bleeding control bundle of care. Injury. 2017; 48: 5–12.
- 21Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015; 313: 471–82.
- 22Yazer MH, Delaney M, Doughty H, Dunbar NM, al-Riyami AZ, Triulzi DJ, et al. It is time to reconsider the risks of transfusing RhD negative females of childbearing potential with RhD positive red blood cells in bleeding emergencies. Transfusion. 2019; 59: 3794–9.
- 23 CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010; 376: 23–32.
- 24Angerman S, Kirves H, Nurmi J. Characteristics of nontrauma patients receiving prehospital blood transfusion with the same triggers as trauma patients: a retrospective observational cohort study. Prehosp Emerg Care. 2022; 26: 263–71.
- 25Pusateri AE, Moore EE, Moore HB, le TD, Guyette FX, Chapman MP, et al. Association of Prehospital Plasma Transfusion with Survival in trauma patients with hemorrhagic shock when transport times are longer than 20 min: a post hoc analysis of the PAMPer and COMBAT clinical trials. JAMA Surg. 2020; 155:e195085.
- 26Woolley T, Thompson P, Kirkman E, Reed R, Ausset S, Beckett A, et al. Trauma hemostasis and oxygenation research network position paper on the role of hypotensive resuscitation as part of remote damage control resuscitation. J Trauma Acute Care Surg. 2018; 84: S3–S13.
- 27Meyer DE, Vincent LE, Fox EE, O'Keeffe T, Inaba K, Bulger E, et al. Every minute counts: time to delivery of initial massive transfusion cooler and its impact on mortality. J Trauma Acute Care Surg. 2017; 83: 19–24.
- 28Yazer MH, Spinella PC, Bank EA, Cannon JW, Dunbar NM, Holcomb JB, et al. THOR-AABB working party recommendations for a prehospital blood product transfusion program. Prehosp Emerg Care. 2021; 1–13. https://doi.org/10.1080/10903127.2021.1995089
- 29Wu J, Vodovotz Y, Abdelhamid S, Guyette FX, Yaffe MB, Gruen DS, et al. Multi-omic analysis in injured humans: patterns align with outcomes and treatment responses. Cell Rep Med. 2021; 2:100478.
- 30Makris M, Iorio A. Prehospital fresh frozen plasma: universal life saver or treatment in search of a target population? Res Pract Thromb Haemost. 2019; 3: 12–4.
- 31Eastridge BJ, Mabry RL, Seguin P, Cantrell J, Tops T, Uribe P, et al. Death on the battlefield (2001–2011): implications for the future of combat casualty care. J Trauma Acute Care Surg. 2012; 73: S431–7.
- 32Drake SA, Holcomb JB, Yang Y, Thetford C, Myers L, Brock M, et al. Establishing a regional trauma preventable/potentially preventable death rate. Ann Surg. 2020; 271: 375–82.
- 33Kalkwarf KJ, Drake SA, Yang Y, Thetford C, Myers L, Brock M, et al. Bleeding to death in a big city: an analysis of all trauma deaths from hemorrhage in a metropolitan area during 1 year. J Trauma Acute Care Surg. 2020; 89: 716–22.
Citing Literature
